Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biomarin Pharmaceut (BMRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,146,352
  • Shares Outstanding, K 176,710
  • Annual Sales, $ 1,314 M
  • Annual Income, $ -117,040 K
  • 36-Month Beta 1.66
  • Price/Sales 13.98
  • Price/Cash Flow N/A
  • Price/Book 6.54

Price Performance

See More
Period Period Low Period High Performance
1-Month
90.19 +14.06%
on 06/28/18
104.46 -1.52%
on 07/17/18
+7.25 (+7.58%)
since 06/19/18
3-Month
80.03 +28.54%
on 04/26/18
104.46 -1.52%
on 07/17/18
+19.25 (+23.02%)
since 04/19/18
52-Week
75.81 +35.69%
on 04/06/18
104.46 -1.52%
on 07/17/18
+15.64 (+17.93%)
since 07/19/17

Most Recent Stories

More News
Pfizer's Hemophilia B Gene Therapy Candidate Enters Phase III

Pfizer (PFE) initiates phase III program on a gene therapy treatment, fidanacogene elaparvovec, for patients with hemophilia B.

ONCE : 82.08 (-3.83%)
BMRN : 102.87 (+0.18%)
PFE : 37.36 (-0.80%)
BMY : 56.54 (-0.60%)
BioMarin to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Thursday, August 2 at 4:30pm ET

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, August 2,...

BMRN : 102.87 (+0.18%)
BioMarin Partners with Believe Limited for 'Breaking Through!' Musical Theater Intensive

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced an exclusive partnership with Believe Limited to produce the 'Breaking Through!' musical theater intensive. The first-of-its-kind program is...

BMRN : 102.87 (+0.18%)
Sarepta's DMD Portfolio Solid, Sole Drug Dependence Concerns

Sarepta Therapeutics' (SRPT) DMD drug sales are rising and pipeline candidates are progressing well. However, dependence on a single product for near-term growth is a concern.

AGLE : 9.31 (-0.53%)
SRPT : 135.53 (+0.14%)
BMRN : 102.87 (+0.18%)
ANIP : 70.56 (-0.42%)
Today's Research Reports on Trending Tickers: BioMarin Pharmaceutical and Arena Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / July 2, 2018 / Major U.S. markets finished higher on Friday, but finished the week lower due to ongoing global trade concerns. The Dow Jones Industrial Average increased 0.23...

BMRN : 102.87 (+0.18%)
BioMarin Announces First Recipients of RARE Scholars Scholarship Program

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that it has awarded the first five recipients of the RARE Scholars program, an annual scholarship for students living with rare disease. The...

BMRN : 102.87 (+0.18%)
Report: Developing Opportunities within American Homes 4 Rent, Invitation Home, Graphic Packaging Holding, Flotek Industries, Sunstone Hotel Investors, and BioMarin Pharmaceutical -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of American Homes 4 Rent (NYSE:AMH),...

GPK : 14.92 (+0.54%)
INVH : 23.57 (+0.51%)
BMRN : 102.87 (+0.18%)
SHO : 16.89 (+0.78%)
AMH : 22.88 (+1.19%)
FTK : 3.03 (+1.00%)
Look for Shares of Biomarin Pharmac to Potentially Rebound after Yesterday's 1.34% Sell Off

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $93.04 to a high of $95.95. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of...

BMRN : 102.87 (+0.18%)
Free Technical Research on BioPharmX and Three More Biotech Equities bio

Stock Research Monitor: BMRN, BTX, and BLUE

BPMX : 0.23 (+15.00%)
BMRN : 102.87 (+0.18%)
BioMarin Pharmaceutical (BMRN) Catches Eye: Stock Jumps 8.5%

BioMarin Pharmaceutical (BMRN) shares rose nearly 9% in the last trading session, amid huge volumes.

GHDX : 58.31 (+4.91%)
BMRN : 102.87 (+0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade BMRN with:

Business Summary

BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment...

See More

Key Turning Points

2nd Resistance Point 104.83
1st Resistance Point 103.85
Last Price 102.87
1st Support Level 101.27
2nd Support Level 99.67

See More

52-Week High 104.46
Last Price 102.87
Fibonacci 61.8% 93.52
Fibonacci 50% 90.13
Fibonacci 38.2% 86.75
52-Week Low 75.81

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar